Skip to main content

Table 1 Baseline characteristics of five groups

From: Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population

 

TyG-BMI quintile

 
 

Q1(97.48–147.69)

Q2(147.72–164.94)

Q3(164.95–182.05)

Q4(182.07–205.33)

Q5(205.34–421.32)

P-value

No. of participants

2850

2850

2851

2849

2851

 

Age (years)

40.18 (8.39)

42.98 (8.70)

44.39 (8.93)*

45.35 (8.97)*

44.77 (8.50)

< 0.001

Weight (kg)

48.32 (5.59)

54.08 (6.16)

59.33 (6.80)

65.00 (7.04)

74.57 (10.04)

< 0.001

Height (cm)

161.50 (7.36)

163.06 (8.31)

164.94 (8.62)

166.74 (8.33)

167.74 (8.16)

< 0.001

BMI (kg/m2)

18.49 (1.30)

20.29 (1.11)

21.75 (1.14)

23.34 (1.26)

26.45 (2.56)

< 0.001

WC (cm)

66.42 (4.84)

71.14 (4.99)

75.57 (5.11)

80.26 (5.01)

87.54 (6.92)

< 0.001

Sex (male)

538 (18.88%)

1046 (36.70%)

1548 (54.30%)

2034 (71.39%)

2245 (78.74%)

< 0.001

NAFLD

11 (0.39%)

56 (1.96%)

198 (6.94%)

612 (21.48%)

1630 (57.17%)

< 0.001

Habit of exercise

438 (15.37%)

548 (19.23%)

547 (19.19%)

497 (17.44%)

440 (15.43%)

< 0.001

ALT (IU/L)

13 (11–17)

14 (11–18)

16 (12–20)

19 (15–25)

25 (18–35)

< 0.001

AST (IU/L)

16 (13–19)**

16 (13–19)

16 (14–20)

18 (14–21)

20.00 (16–25)

< 0.001

GGT (IU/L)

12 (10–14)

13 (10–16)

14.00 (11–19)

17.00 (13–24)

22.00 (16–33)

< 0.001

HDL-C (mmol/L)

1.73 (0.39)

1.62 (0.38)

1.48 (0.36)

1.32 (0.31)

1.15 (0.27)

< 0.001

TC (mmol/L)

4.73 (0.78)

4.99 (0.81)

5.11 (0.86)

5.28 (0.82)

5.50 (0.88)

< 0.001

TG (mmol/L)

0.41 (0.30–0.53)

0.56 (0.44–0.73)

0.71 (0.55–0.93)

0.95 (0.72–1.24)

1.42 (1.03–1.94)

< 0.001

FPG (mmol/L)

4.88 (0.37)

5.03 (0.38)

5.16 (0.38)

5.27 (0.36)

5.40 (0.36)

< 0.001

TyG

7.33 (0.45)

7.73 (0.39)

7.98 (0.40)

8.29 (0.41)

8.72 (0.49)

< 0.001

HbA1c (%)

5.10 (4.90–5.35)

5.10 (4.91–5.40)***

5.10 (4.90–5.40)

5.20 (5.00–5.40)

5.20 (5.00–5.50)

< 0.001

SBP (mmHg)

104.98 (12.14)

108.99 (12.62)

113.40 (12.96)

117.90 (13.62)

124.40 (14.44)

< 0.001

DBP (mmHg)

64.91 (8.30)

67.66 (9.06)

70.55 (9.22)

74.01 (9.56)

78.48 (9.93)

< 0.001

Drinking status

     

< 0.001

 Non or small

2606 (91.44%)

2451 (86.00%)

2305 (80.85%)

2197 (77.11%)

2246 (78.78%)

 

 Light

209 (7.33%)

307 (10.77%)

406 (14.24%)

434 (15.23%)

402 (14.10%)

 

 Moderate

35 (1.23%)

92 (3.23%)

140 (4.91%)

218 (7.65%)

203 (7.12%)

 

Smoking status

     

< 0.001

 Non

2299 (80.67%)

2018 (70.81%)

1732 (60.75%)

1387 (48.68%)

1310 (45.95%)

 

 Former

246 (8.63%)

406 (14.25%)

529 (18.55%)

690 (24.22%)

688 (24.13%)

 

 Current

305 (10.70%)

426 (14.95%)

590 (20.69%)

772 (27.10%)

853 (29.92%)

 
  1. Values were expressed as mean (SD) or medians (quartile interval) or n (%). Abbreviations: NAFLD: Nonalcoholic fatty liver disease; BMI body mass index; TyG the triglyceride-glucose index; TyG-BMI triglyceride glucose-body mass index; WC Waist circumference; ALT alanine aminotransferase; AST aspartate aminotransferase; GGT gamma-glutamyl transferase; HDL-C high-density lipoprotein cholesterol; TC total cholesterol; TG triglyceride; HbA1c hemoglobin A1c; FPG fasting plasma glucose; SBP systolic blood pressure; DBP Diastolic blood pressure. *P > 0.05 vs Q5. **P > 0.05 vs Q2. ***P > 0.05 vs Q1, Q3. Other variables with no special mark on the upper right corner had P values < 0.05 after pair-wise comparison